Medicare Benefits Schedule - Item 35645

Cervix, ablation by electrocoagulation diathermy, laser or cryotherapy, with colposcopy, including any local anaesthesia or biopsies, in conjunction with ablative therapy of additional areas of biopsy proven high grade intraepithelial lesions of one or more sites of the vagina, vulva, urethra or anus, for previously biopsy confirmed HSIL (CIN2/3) in a patient with a Type 1 of 2 (completely visible) transformation zone, if there is:
(a) no evidence of invasive or glandular disease; and
(b) no discordance between cytology and previous histology;
not being a service associated with a service to which item 35647 or 35648 applies 

Multiple Operation Rule

(Anaes.)

Fee: $336.90 Benefit: 75% = $252.70 85% = $286.40

(See para TN.8.45, TN.8.234 of explanatory notes to this Category)

• Previous - Item 35644
• Next - Item 35647

The term "previously confirmed intraepithelial neoplastic changes of the cervix" in these items refers to diagnosis made by either cytologic, colposcopic or histologic methods. This may also include persistent human papilloma virus (HPV) changes of the cervix.

Related Items: 35644 35645 35647 35648

-       Not for use in patients with a type 3 transformation zone.

-       A second ablative treatment for a HSIL (CIN2/3) should NOT be performed (an excisional treatment is indicated in this situation).

-       Treatment of high-grade lesions (CIN 2/3) in an immunocompromised patients should be by excisional methods only.

Related Items: 35644 35645